- Home
- ARQT vs LADR Comparison
ARQT vs LADR Comparison
Compare ARQT & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- LADR
- Stock Information
- Founded
- ARQT 2016
- LADR 2008
- Country
- ARQT United States
- LADR United States
- Employees
- ARQT N/A
- LADR N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- LADR Real Estate Investment Trusts
- Sector
- ARQT Health Care
- LADR Real Estate
- Exchange
- ARQT Nasdaq
- LADR Nasdaq
- Market Cap
- ARQT 1.7B
- LADR 1.5B
- IPO Year
- ARQT 2020
- LADR 2014
- Fundamental
- Price
- ARQT $15.00
- LADR $11.13
- Analyst Decision
- ARQT Strong Buy
- LADR Strong Buy
- Analyst Count
- ARQT 6
- LADR 5
- Target Price
- ARQT $18.80
- LADR $13.15
- AVG Volume (30 Days)
- ARQT 2.0M
- LADR 762.7K
- Earning Date
- ARQT 08-13-2025
- LADR 07-24-2025
- Dividend Yield
- ARQT N/A
- LADR 8.27%
- EPS Growth
- ARQT N/A
- LADR 7.86
- EPS
- ARQT N/A
- LADR 0.82
- Revenue
- ARQT $212,819,000.00
- LADR $259,161,000.00
- Revenue This Year
- ARQT $61.15
- LADR N/A
- Revenue Next Year
- ARQT $37.98
- LADR $16.49
- P/E Ratio
- ARQT N/A
- LADR $13.58
- Revenue Growth
- ARQT 100.03
- LADR 1.39
- 52 Week Low
- ARQT $7.86
- LADR $9.68
- 52 Week High
- ARQT $17.75
- LADR $12.48
- Technical
- Relative Strength Index (RSI)
- ARQT 60.23
- LADR 63.49
- Support Level
- ARQT $13.06
- LADR $10.90
- Resistance Level
- ARQT $15.36
- LADR $11.23
- Average True Range (ATR)
- ARQT 0.66
- LADR 0.17
- MACD
- ARQT 0.12
- LADR 0.03
- Stochastic Oscillator
- ARQT 82.57
- LADR 85.42
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.